Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Data normalization considerations for digital tumor dissection.

Newman AM, Gentles AJ, Liu CL, Diehn M, Alizadeh AA.

Genome Biol. 2017 Jul 5;18(1):128. doi: 10.1186/s13059-017-1257-4.

2.

Antitumor Effect of KML-B-Treated Dendritic Cells via Induction of Lymphocyte Activation.

Kim JJ, Hwang YH, Kang KY, Lee SJ, Kim JB, Choi J, Yee ST.

J Immunol Res. 2017;2017:2471627. doi: 10.1155/2017/2471627. Epub 2017 May 29.

3.

Cerebral Gluconeogenesis and Diseases.

Yip J, Geng X, Shen J, Ding Y.

Front Pharmacol. 2017 Jan 4;7:521. doi: 10.3389/fphar.2016.00521. eCollection 2016. Review.

4.

Cell-Intrinsic Barriers of T Cell-Based Immunotherapy.

Ghoneim HE, Zamora AE, Thomas PG, Youngblood BA.

Trends Mol Med. 2016 Dec;22(12):1000-1011. doi: 10.1016/j.molmed.2016.10.002. Epub 2016 Nov 4. Review.

PMID:
27825667
5.
6.

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells.

Kamata T, Suzuki A, Mise N, Ihara F, Takami M, Makita Y, Horinaka A, Harada K, Kunii N, Yoshida S, Yoshino I, Nakayama T, Motohashi S.

Cancer Immunol Immunother. 2016 Dec;65(12):1477-1489. Epub 2016 Sep 15.

7.

Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.

Shi L, Yu B, Cai CH, Huang JD.

AMB Express. 2016 Dec;6(1):56. doi: 10.1186/s13568-016-0226-8. Epub 2016 Aug 24.

8.

Update on the challenges and recent advances in cancer immunotherapy.

Baronzio G, Parmar G, Shubina IZh, Cassutti V, Giuli S, Ballerini M, Kiselevsky M.

Immunotargets Ther. 2013 Jun 15;2:39-49. doi: 10.2147/ITT.S30818. eCollection 2013. Review.

9.

Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.

Song J, Lee J, Kim J, Jo S, Kim YJ, Baek JE, Kwon ES, Lee KP, Yang S, Kwon KS, Kim DU, Kang TH, Park YY, Chang S, Cho HJ, Kim SC, Koh SS, Kim S.

Oncotarget. 2016 Aug 9;7(32):51840-51853. doi: 10.18632/oncotarget.10123.

10.

Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation.

Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, James T, Rincon M.

Breast Cancer Res Treat. 2016 Jun;157(3):461-74. doi: 10.1007/s10549-016-3839-3. Epub 2016 Jun 1.

11.

Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases.

Rippaus N, Taggart D, Williams J, Andreou T, Wurdak H, Wronski K, Lorger M.

Oncotarget. 2016 Jul 5;7(27):41473-41487. doi: 10.18632/oncotarget.9445.

12.

New Strategies for the Treatment of Solid Tumors with CAR-T Cells.

Zhang H, Ye ZL, Yuan ZG, Luo ZQ, Jin HJ, Qian QJ.

Int J Biol Sci. 2016 Apr 28;12(6):718-29. doi: 10.7150/ijbs.14405. eCollection 2016. Review.

13.

Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6.

Stadler CR, Bähr-Mahmud H, Plum LM, Schmoldt K, Kölsch AC, Türeci Ö, Sahin U.

Oncoimmunology. 2015 Oct 29;5(3):e1091555. eCollection 2016 Mar.

14.

Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration.

Sawe RT, Kerper M, Badve S, Li J, Sandoval-Cooper M, Xie J, Shi Z, Patel K, Chumba D, Ofulla A, Prosperi J, Taylor K, Stack MS, Mining S, Littlepage LE.

BMC Cancer. 2016 Mar 10;16:204. doi: 10.1186/s12885-016-2204-6.

15.

Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.

Buhrmann C, Shayan P, Popper B, Goel A, Shakibaei M.

Nutrients. 2016 Mar 5;8(3):145. doi: 10.3390/nu8030145.

16.

Cancer stem cells and chemoresistance: The smartest survives the raid.

Zhao J.

Pharmacol Ther. 2016 Apr;160:145-58. doi: 10.1016/j.pharmthera.2016.02.008. Epub 2016 Feb 17. Review.

17.

Large molecular systems landscape uncovers T cell trapping in human skin cancer.

Hillert R, Gieseler A, Krusche A, Humme D, Röwert-Huber HJ, Sterry W, Walden P, Schubert W.

Sci Rep. 2016 Jan 13;6:19012. doi: 10.1038/srep19012.

18.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AM, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HP, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HM, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-304. doi: 10.1016/j.semcancer.2015.09.007. Review.

19.

PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB.

Karyampudi L, Lamichhane P, Krempski J, Kalli KR, Behrens MD, Vargas DM, Hartmann LC, Janco JM, Dong H, Hedin KE, Dietz AB, Goode EL, Knutson KL.

Cancer Res. 2016 Jan 15;76(2):239-50. doi: 10.1158/0008-5472.CAN-15-0748. Epub 2015 Nov 13.

20.

Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Khan MA, Hsu JL, Assiri AM, Broering DC.

Clin Exp Immunol. 2016 Feb;183(2):175-86. doi: 10.1111/cei.12713. Epub 2015 Nov 5. Review.

Supplemental Content

Support Center